These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29786810)

  • 1. [Epilepsy and comorbid neurodevelopmental disorders].
    Nordin V; Olsson IB; Tomson T
    Lakartidningen; 2018 May; 115():. PubMed ID: 29786810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First episode psychosis and comorbid ADHD, autism and intellectual disability.
    Strålin P; Hetta J
    Eur Psychiatry; 2019 Jan; 55():18-22. PubMed ID: 30384107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key issues in addressing the comorbidity of attention deficit hyperactivity disorder and pediatric epilepsy.
    Salpekar JA; Mishra G
    Epilepsy Behav; 2014 Aug; 37():310-5. PubMed ID: 24835083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacotherapy of ADHD in adults with comorbid depression].
    Ohlmeier MD
    Psychiatr Prax; 2007 Sep; 34 Suppl 3():S296-9. PubMed ID: 17786887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of psychotropic drugs in epilepsy: what every neurologist should know.
    Kanner AM
    Semin Neurol; 2008 Jul; 28(3):379-88. PubMed ID: 18777484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing therapy of seizures in children and adolescents with ADHD.
    Aldenkamp AP; Arzimanoglou A; Reijs R; Van Mil S
    Neurology; 2006 Dec; 67(12 Suppl 4):S49-51. PubMed ID: 17190923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gap.
    Levy E; Traicu A; Iyer S; Malla A; Joober R
    Can J Psychiatry; 2015 Mar; 60(3 Suppl 2):S48-52. PubMed ID: 25886680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological treatment in adults with attention deficit hyperactivity disorder].
    Frölich J; Lehmkuhl G
    Nervenarzt; 2004 Nov; 75(11):1074-82. PubMed ID: 15549216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations.
    Hamoda HM; Guild DJ; Gumlak S; Travers BH; Gonzalez-Heydrich J
    Expert Rev Neurother; 2009 Dec; 9(12):1747-54. PubMed ID: 19951134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies.
    Santos K; Palmini A; Radziuk AL; Rotert R; Bastos F; Booij L; Fernandes BS
    Dev Med Child Neurol; 2013 Jul; 55(7):654-60. PubMed ID: 23480530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
    Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F
    J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Autism and its Comorbidities and the Relationship with Maternal Psychopathology: A National Population-Based Study.
    Mohammadi MR; Ahmadi N; Khaleghi A; Zarafshan H; Mostafavi SA; Kamali K; Rahgozar M; Ahmadi A; Hooshyari Z; Alavi SS; Shakiba A; Salmanian M; Molavi P; Sarraf N; Hojjat SK; Mohammadzadeh S; Amiri S; Arman S; Ghanizadeh A
    Arch Iran Med; 2019 Oct; 22(10):546-553. PubMed ID: 31679355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological management of a youth with ADHD and a seizure disorder.
    Gonzalez-Heydrich J; Weiss M; Connolly M; Wambera K; Jan JE; Plioplys S; Dunn DW; Kratochvil CJ
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1527-32. PubMed ID: 17135999
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy.
    Merrill RM; Thygerson SM; Palmer CA
    Pharmacopsychiatry; 2016 Mar; 49(2):45-50. PubMed ID: 26829453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
    Shyu YC; Yuan SS; Lee SY; Yang CJ; Yang KC; Lee TL; Wang LJ
    Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations for ADHD in the child with epilepsy and the child with migraine.
    Downs J; Giust J; Dunn DW
    Expert Rev Neurother; 2017 Sep; 17(9):861-869. PubMed ID: 28749241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epilepsy in a large cohort of children diagnosed with attention deficit/hyperactivity disorders (ADHD).
    Socanski D; Aurlien D; Herigstad A; Thomsen PH; Larsen TK
    Seizure; 2013 Oct; 22(8):651-5. PubMed ID: 23711613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Models of drug treatment in the attention deficit disorder with hyperactivity].
    Etchepareborda MC
    Rev Neurol; 2002 Feb; 34 Suppl 1():S98-S106. PubMed ID: 12447798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India.
    Manohar H; Kuppili PP; Kandasamy P; Chandrasekaran V; Rajkumar RP
    Asian J Psychiatr; 2018 Mar; 33():68-73. PubMed ID: 29544110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention deficit/hyperactivity disorder across the lifespan.
    Wilens TE; Biederman J; Spencer TJ
    Annu Rev Med; 2002; 53():113-31. PubMed ID: 11818466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.